McCrystal, M R <br/><br/>
Phase I study of the cytotoxic agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  1999 
 - 39-44 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s002800050942  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acridines--administration & dosage<br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Facial Pain--chemically induced<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy